Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Winston Crasto

Winston Crasto is Consultant in Diabetes & Endocrinology at George Eliot Hospital NHS Trust

Recent stories

  • Due to rising obesity and changes in the ethnic make up of the UK population, the number of people in the UK with diabetes is expected to rise by over 50% by 2030. In the image, polarised light micrograph of glynase, used to treat Type 2 diabetes

    Type 2 diabetes: pharmacological management strategiesSubscription

    3 NOV 2015Comments (2)

    Current and future treatment options for the management of patients with type 2 diabetes.

  • Identifying patients at risk of diabetes

    Identifying patients at risk of diabetesSubscription

    28 OCT 2014Comments (2)

    With 11.5 million people at risk in the UK, it is essential to recognise the signs and symptoms of type 1 diabetes and type 2 diabetes.

  • Question from practice: Could you spot diabetic gastroparesis?Subscription

    PJ, 19/26 April 2014, Vol 292, No 7806/7

    Hyperglycaemia is a key factor in the pathophysiology of diabetic neuropathy, but other changes also contribute. In type 2 diabetes, dyslipidaemia and disturbances in neuronal insulin sensitivity are thought to play a major role. Changes in insulin signalling are important in patients with type 1 diabetes.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.